NCT06695689View on ClinicalTrials.gov

An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions

Solid Tumor

Interventions

DRUG

LM303

Treatment with LM303 injection

Trial Locations (1)

300000

RECRUITING

Tianjin Beichen Hospital, Tianjin

All Listed Sponsors

lead

Suzhou BlueHorse Therapeutics Co., Ltd.

INDUSTRY